Ameriabank has signed long-term subordinated loan agreements with a total volume of $17.5M during recent months, with an option to increase by $15M, if required. The $17.5M sub debt funds, attracted from several partner institutions, qualify as Bank Tier 2 capital under Basel III framework and are aimed at strengthening the overall capital position of the Bank.

Part of the subordinated debt was attracted from our long standing partners at Symbiotics aimed at supporting Armenian economy during recovery by financing primarily small and medium business. This is the second subordinated loan agreement with Symbiotics since the beginning of the pandemic, with a $15M subordinated loan agreement signed in late 2020.

Vincent Lehner, Head of Markets at Symbiotics, made his first post-Covid business trip to Armenia to discuss Ameriabank and Symbiotics long-standing collaboration, as well as overall economic prospects.

“I think it’s a good moment to invest in Armenia. We see Armenia as a very good base for us, for the development of our business. We invest in the future, in the future of the bank, in the future of the country, and in the future of our company – Symbiotics, as well. Ameria is a great partner. Our partnership really shows that we are aligned, we have the same objectives, we can deliver together what we want, to achieve and support the businesses”, said Lehner in a fresh interview.